Cell Therapeutics, Stock Price 8,240 KRW (-4.19%)... Bulletin Board 'Bustling'
At this time, posts about Cellma Therapeutics are rapidly increasing on portals and securities communities, while foreign investors are tentatively recorded to have net sold 2,807 shares today. Cellma Therapeutics is known as a company distributing gift certificate discounts and dental materials.
As of 1:30 PM on the 18th, Cellma Therapeutics' stock price is 8,240 KRW, down 4.19% from the previous day, with a trading volume of 1,097,059 shares, which is about 14.45% of the 5-day average trading volume. On March 11, Cellma Therapeutics became a market issue with the headline "Russia COVID-19 vaccine contract manufacturing... surged 18.16%."
In addition to Cellma Therapeutics, posts by investors are also rapidly increasing regarding Devsisters (194480), Solbon (035610), and Kia Motors (000270).
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- One in 77 Koreans Exposed to Drugs... Enough Money for 6,600 Luxury Gangnam Apartments Circulates in Drug Market [ChwiYakGukga] ⑩
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※Source: AI Investment Assistant AI Lasso
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
